(Q53334133)

13 May 2018

title

Chemotherapy-induced nausea and vomiting in routine practice: a European perspective. (English)

1 reference

13 May 2018

1 reference

Agnes Glaus

1 reference

13 May 2018

Cornelia Knipping

1 reference

13 May 2018

Rudolf Morant

1 reference

13 May 2018

Christel Böhme

1 reference

13 May 2018

Burkhard Lebert

1 reference

13 May 2018

Frank Beldermann

1 reference

13 May 2018

Bernhard Glawogger

1 reference

13 May 2018

Paz Fernandez Ortega

1 reference

13 May 2018

André Hüsler

1 reference

13 May 2018

Robert Deuson

1 reference

13 May 2018

publication date

1 October 2004

1 reference

13 May 2018

Supportive Care in Cancer

published in

1 reference

13 May 2018

volume

1 reference

13 May 2018

issue

1 reference

13 May 2018

page(s)

708-715

1 reference

13 May 2018

Assessment of the multiple dimensions of nausea: the Nausea Profile (NP)

cites work

1 reference

12 December 2020

Quality of life consequences of chemotherapy-induced emesis

1 reference

12 December 2020

5-HT3 receptor antagonists in the control of cisplatin-induced delayed emesis

1 reference

12 December 2020

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

1 reference

12 December 2020

Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development

1 reference

12 December 2020

Chemotherapy-induced emesis: management of early and delayed emesis in milder emetogenic regimens.

1 reference

12 December 2020

The role of serotonin as a mediator of emesis induced by different stimuli

1 reference

12 December 2020

Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin

1 reference

12 December 2020

ASHP Therapeutic Guidelines on the Pharmacologic Management of Nausea and Vomiting in Adult and Pediatric Patients Receiving Chemotherapy or Radiation Therapy or Undergoing Surgery

1 reference

12 December 2020

Frequency and clinical implications of delayed nausea and delayed emesis

1 reference

12 December 2020

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group

1 reference

12 December 2020

Serotonin mechanisms in chemotherapy-induced emesis in cancer patients

1 reference

12 December 2020

On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993.

1 reference

12 December 2020

5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy

1 reference

12 December 2020

Patient expectations as predictor of chemotherapy-induced nausea

1 reference

12 December 2020

Chemotherapy-induced nausea and vomiting

1 reference

12 December 2020

Delayed emesis: incidence, pattern, prognostic factors and optimal treatment

1 reference

12 December 2020

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

1 reference

12 December 2020

Delayed emesis following anticancer chemotherapy

1 reference

12 December 2020

Nausea and vomiting and cancer patients' quality of life: a discussion of Professor Selby's paper

1 reference

12 December 2020

Double-blind randomized cross-over trial comparing methylprednisolone with placebo in chemotherapy-induced nausea and vomiting: a study with special reference to efficacy parameters

1 reference

12 December 2020

1 reference

12 December 2020

Patients’ self-reported functional status after granisetron or ondansetron therapy to prevent chemotherapy-induced nausea and vomiting at six cancer centers

1 reference

12 December 2020

How do we manage patients with refractory or breakthrough emesis?

1 reference

12 December 2020

Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.

1 reference

12 December 2020

Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices

1 reference

12 December 2020

Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.

1 reference

12 December 2020

Antiemetic guidelines: creating a more practical treatment approach

1 reference

12 December 2020

NCCN antiemesis practice guidelines

1 reference

12 December 2020

Progress in preventing chemotherapy-induced nausea and vomiting

1 reference

12 December 2020

Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational study

1 reference

12 December 2020

Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC)

1 reference

12 December 2020

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update.

1 reference

12 December 2020

10.1007/S00520-004-0662-X

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018